Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling Mar 5, 2014
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 Mar 3, 2014
Navidea Announces Priority Review for the sNDA to Expand Lymphoseek® Labeling for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer Feb 18, 2014
Navidea Biopharmaceuticals Announces the Presentation of Manocept™ Data at Keystone Symposia for Molecular Cell Biology of Macrophages in Human Disease Feb 13, 2014
Navidea Biopharmaceuticals Announces Positive Initial Results in Single-Center Cohort from Phase 2b Trial of NAV4694 in Subjects with Mild Cognitive Impairment (MCI) Feb 6, 2014
